Logotype for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Munich RE (MUV2) CMD 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

CMD 2025 summary

7 Jan, 2026

Strategic achievements, vision, and outlook

  • Ambition 2025 targets were exceeded, with net income rising from €2.9bn in 2020 to €6bn in 2025 and ROE increasing from 11.9% to around 18%, doubling previous years’ results.

  • All business segments—P&C Reinsurance, Life & Health Reinsurance, Global Specialty Insurance, and ERGO—contributed to growth and stability.

  • Total shareholder return reached 171% from 2021 to 2025, outperforming peers.

  • Diversification, disciplined capital management, and underwriting excellence enabled resilience through macroeconomic and geopolitical challenges.

  • Ambition 2030 aims to further boost net income beyond €6bn, maintain ROE above 18%, and balance financial growth with societal impact.

Financial and capital management targets

  • New 2030 targets: ROE >18%, EPS growth >8% CAGR, payout ratio >80%, and Solvency II ratio >200%.

  • Cost savings of €600m targeted by 2030, with €200m expected next year, counteracting inflation and supporting automation.

  • Investment returns to rise, with running yields expected to exceed 3% by 2030, driven by higher reinvestment yields and alternative assets.

  • Capital repatriation to shareholders will exceed 80% of net income annually, with dividend growth aligned to EPS growth.

  • Solvency II target floor set at >200%, aligning with AA rating and ensuring flexibility for growth post-large events.

Business segment strategies and growth

  • ERGO targets >18% ROE by 2030, focusing on market leadership in Germany, international expansion, and digital transformation.

  • ERGO’s insurance revenue is projected to grow to €26–30bn by 2030, with improved combined ratios in Germany and International.

  • Reinsurance aims for global leadership in P&C, strong Life & Health expansion, and GSI-driven diversification with less volatile earnings.

  • Specialty insurance (GSI) will leverage market growth, disciplined underwriting, and volatility management for above-market expansion.

  • Cost discipline, technology investments, and global IT harmonization are central enablers across all segments.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more